Heterogeneous transmural gene expression of calcium-handling proteins and natriuretic peptides in the failing human heart

Cardiovascular Research

Volumn 43, Issue 2, 1999, Pages 323-331

  Prestle, Jürgen ^a   Dieterich, Sabine ^b   Preuss, Michael ^b   Bieligk, Ursula ^b   Hasenfuss, Gerd ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Ca pump; Experimental (Discipline); Gene expression; Heart (Object); Heart failure; Human (Species); Molecular biology (Level); Na Ca exchanger; Natriuretic peptide

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CALCIUM BINDING PROTEIN; CALCIUM ION; CALSEQUESTRIN; MESSENGER RNA; NATRIURETIC FACTOR; PHOSPHOLAMBAN;

ADULT; AGED; ARTICLE; CALCIUM HOMEOSTASIS; CALCIUM MOBILIZATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HEART FAILURE; HEART LEFT VENTRICLE WALL; HUMAN; HUMAN TISSUE; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOPLASMIC RETICULUM; TISSUE DISTRIBUTION;

ADULT; AGED; ATRIAL NATRIURETIC FACTOR; BLOTTING, WESTERN; CALCIUM; CALCIUM-BINDING PROTEINS; CALCIUM-TRANSPORTING ATPASES; CALSEQUESTRIN; ENDOCARDIUM; GENE EXPRESSION; HEART FAILURE, CONGESTIVE; HUMANS; MIDDLE AGED; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; PERICARDIUM; RNA, MESSENGER; SARCOPLASMIC RETICULUM; SODIUM-CALCIUM EXCHANGER;

EID: 0033178372     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00119-4     Document Type: Article

References (39)

1. Opie L.H. The heart: physiology and metabolism. 1991;Raven Press, New York, NY.
2. Ruskoaho H., Leskinen H., Taskinen J.M.P., Mäntymaa P., Leppäluoto O.V. J Mechanisms of mechanical load-induced atrial natriuretic peptide secretion: role of endothelin, nitric oxide, and angiotensin II. J Mol Med. 75:1997;876-885.
3. Kinnunen P., Vuolteenaho O., Marttila M., Ruskoaho H. Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching. Endocrinology. 132:1993;1961-1970.
4. Muders F., Kromer E.P., Griese D.P., et al. Evaluation of plasma natriuretic peptides as markers for left ventricular dysfunction. Am Heart J. 134:1997;442-449.
5. McDonagh T.A., Robb S.D., Murdoch D.R., et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet. 351:1998;9-13.
6. Mirsky I. Ventricular and arterial wall stresses based on large deformation analysis. Biophys J. 13:1973;1141-1159.
7. Yin F.C.P. Ventricular wall stress. Circ Res. 49:1981;829-842.
8. Katz A.M. Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure. N Engl J Med. 322:1990;100-110.
9. Morgan J.P. Abnormal intracellular modulation of calcium as a major cause of cardiac contractile dysfunction. New Engl J Med. 325:1991;625-632.
10. Dhalla N.S., Wang X., Beamish R.E. Intracellular calcium handling in normal and failing hearts. Exp Clin Cardiol. 1:1996;7-20.
11. Gwathmey J.K., Slawsky M.T., Hajjar R.J., Briggs G.M., Morgan J.P. Role of intracellular calcium handling in force-interval relationships of human ventricular myocardium. J Clin Invest. 85:1990;1599-1613.
12. Hasenfuss G., Mulieri L.A., Leavitt J.B., et al. Alterations of contractile function and excitation-contraction coupling in dilated cardiomyopathy. Circ Res. 70:1992;1225-1232.
13. Pieske B., Kretschmann B., Meyer M., et al. Alterations in intracellular calcium handling associated with the inverse force-frequency relation in human dilated cardiomyopathy. Circulation. 92:1995;1169-1178.
14. Pieske B., Sütterlin M., Schmidt-Schweda S., et al. Diminished post-rest potentiation of contractile force in human dilated cardiomyopathy. J Clin Invest. 98:1996;764-776.
15. Mercadier J.J., Lompré A.M., Duc P., et al. Altered sarcoplasmic reticulum Ca-ATPase gene expression in the human ventricle during end-stage heart failure. J Clin Invest. 85:1990;305-309.
16. Arai M., Alpert N.R., McLennan D.H., Barton P., Periasamy M. Alterations in sarcoplasmic reticulum gene expression in human heart failure: a possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ Res. 72:1993;463-469.
17. 2+-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium. Circulation. 90:1994;653-657.
18. Meyer M., Schillinger W., Pieske B., et al. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation. 92:1995;778-784.
19. 2+-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. Circulation. 92:1995;3220-3228.
20. 2+-ATPase in failing and nonfailing human hearts. Cardiovasc Res. 31:1996;625-632.
21. Mulieri L.A., Hasenfuss G., Ittleman F., Blanchard E.M., Alpert N.R. Protection of human left ventricular myocardium from cutting injury with 2,3-butanedione monoxime. Circ Res. 65:1992;1441-1444.
22. Lowry O.H., Roseborough N.J., Farr A.L., Randall R.J. Protein measurements with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
23. 2+-ATPase gene. J Biol Chem. 263:1988;15024-15031.
24. 2+ exchanger cDNA. Proc Natl Acad Sci. USA. 89:1992;4769-4773.
25. Seidman C.E., Duby A.D., Choi E., et al. The structure of rat preproatrial natriuretic factor as defined by a complementary cDNA clone. Science. 225:1984;324-326.
26. Seilhamer J.J., Arfsten A.E., Miller J.A., et al. Human and canine gene homologs of porcine brain natriuretic peptide. Biochem Biophys Res Commun. 165:1989;650-658.
27. Tokunaga K., Nakamura Y., Sakata K., et al. Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Cancer Res. 47:1987;5616-5619.
28. Koss K.L., Ponniah S., Jones W.K., Grupp I.L., Kranias E.G. Differential phospholamban gene expression in murine cardiac compartments. Circ Res. 77:1995;342-353.
29. 2+ exchanger in end-stage human heart failure. Circ Res. 75:1994;443-453.
30. 2+ exchanger in failing human myocardium. Circulation. 94:1996;992-1002.
31. Murphree S.S., Saffitz J.E. Distribution of β-adrenergic receptors in failing human myocardium: Implications for mechanisms of downregulation. Circulation. 79:1989;1214-1225.
32. Beau S.L., Tolley T.K., Saffitz J.E. Heterogeneous transmural distribution of β-adrenergic receptor subtypes in failing human hearts. Circulation. 88:1993;2501-2509.
33. Bugaisky L.B., Anderson P.G., Hall R.S., Bishop S.P. Differences in myosin isoform expression in the subepicardial and subendocardial myocardium during cardiac hypertrophy in the rat. Circ Res. 66:1990;1127-1132.
34. Dool J.S., Mak A.S., Friberg P., et al. Regional myosin heavy chain expression in volume and pressure overload induced cardiac hypertrophy. Acta Physiol Scand. 155:1995;397-404.
35. Kirk E.S., Honig C.R. Nonuniform distribution of blood flow and gradients of oxygen tension within the heart. Am J Physiol. 207:1964;661-668.
36. Takala T.E.S., Ruskoaho H.J., Hassinen I.E. Transmural distribution of cardiac glucose uptake in rat during physical exercise. Am J Physiol. 244:1983;H132-H137.
37. Bache R.J., Vrobel T.R., Ring W.S., Emery R.W., Andersen R.W. Regional myocardial blood flow during exercise in dogs with chronic left ventricular hypertrophy. Circ Res. 48:1981;76-87.
38. Smolich J.J., Weissberg P.L., Friberg P., Broughton A., Korner P.I. Left ventricular blood flow during aortic pressure reduction in hypertensive dogs. Hypertension. 18:1991;665-673.
39. Drouin E., Charpentier F., Gauthier C., Laurent K., LeMarec H. Electrophysiologic characteristics of cells spanning the left ventricular wall of human heart: Evidence for presence of M cells. J Am Coll Cardiol. 26:1995;185-192.